Inventor · disambiguated record
Remi Palmantier
Also filed as: PALMANTIER REMI · PALMANTIER REMI M · PALMANTIER RÉMI
4 granted patents·14 pending applications·33 citations·filing 2001–2022
70Inventor score
Top patents by PatentIndex Score
18 records- 0192US8987423B2MAGE antigen binding proteinsBERGERON ALAIN·Filed 2011·Granted Mar 24, 2015·22 cites·9 claims
- 0288US8309096B2Fusion proteinBLAIS NORMAND·Filed 2009·Granted Nov 13, 2012·11 cites·5 claims
- 0352US2004202648A1VaccinesFiled 2004·Application pending·0 cites
- 0452US2008249013A1VaccinesGLAXOSMITHKLINE BIOLOG SA·Filed 2008·Application pending·0 cites
- 0550US2006147477A1Immunogenic compositionsGLAXO GROUP LTD·Filed 2003·Application pending·0 cites
- 0648US2004138112A1VaccinesFiled 2003·Application pending·0 cites
- 0748US2007243196A1Mage-3 and NY-ESO-1 Based Polyvalent Vaccine for Cancer ImmunotherapyGLAXOSMITHKLINE BIOLOG SA·Filed 2005·Application pending·0 cites
- 0847US7439320B2Cripto tumour polypeptideGLAXOSMITH KLINE BIOLOG S A·Filed 2001·Granted Oct 21, 2008·0 cites·3 claims
- 0947US2012321694A1Compositions and usesLAROCQUE DANIEL·Filed 2012·Application pending·0 cites
- 1047US2006140965A1Immunogenic compositions comprising a xenogenic prostate protein p501sCASSART JEAN-POL·Filed 2003·Application pending·0 cites
- 1146US2008187535A1VaccineBLAIS NORMAND·Filed 2008·Application pending·0 cites
- 1246US2023165950A1Immunogenic composition comprising cyaa-derived polypeptide promoting a th1/th17-oriented immune responseGENKYOTEX·Filed 2022·Application pending·0 cites
- 1339US2012328605A1Compositions and usesLAROCQUE DANIEL·Filed 2012·Application pending·0 cites
- 1438US8916514B2CASB7439 constructsBLAIS NORMAND·Filed 2010·Granted Dec 23, 2014·0 cites·16 claims
- 1538US2014294849A1Compositions and usesLAROCQUE DANIEL·Filed 2012·Application pending·0 cites
- 1636US2019307875A1Immunogenic composition comprising cyaa-derived polypeptide promoting a th1/th17-oriented immune responseGENKYOTEX·Filed 2017·Application pending·0 cites
- 1733US2013216614A1Immunogenic compositions and methods for treating nuerologic disordersHALLE MAXIME·Filed 2011·Application pending·0 cites
- 1833US2003165503A1Vaccine for the treatment of atherosclerosisFiled 2001·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →